RECRUITING

Nasal Antisepsis for C. Auris Prevention

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a randomized, controlled, open-label trial of effect of 10% povidone iodine intranasal antisepsis on the detection of Candida auris.

Official Title

Impact of Nasal Antisepsis on Candida Auris Colonization

Quick Facts

Study Start:2024-01-29
Study Completion:2028-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06282510

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * History of C. auris colonization or infection
  2. * Patient in a participating facility
  1. * History of severe allergy to iodine-based products, defined as anaphylaxis or rash
  2. * Currently breastfeeding or pregnant
  3. * Non-English language speaking

Contacts and Locations

Study Contact

Sarah E. Sansom, DO
CONTACT
3125636201
sarah_e_sansom@rush.edu
Mary K. Hayden, MD
CONTACT
3129428727
mhayden@rush.edu

Principal Investigator

Mary K. Hayden, MD
PRINCIPAL_INVESTIGATOR
Rush University Medical Center

Study Locations (Sites)

Rush University Medical Center
Chicago, Illinois, 60612
United States
RML Specialty Hospital
Chicago, Illinois, 60624
United States
RML Specialty Hospital
Hinsdale, Illinois, 60521
United States

Collaborators and Investigators

Sponsor: Mary K Hayden

  • Mary K. Hayden, MD, PRINCIPAL_INVESTIGATOR, Rush University Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-01-29
Study Completion Date2028-12

Study Record Updates

Study Start Date2024-01-29
Study Completion Date2028-12

Terms related to this study

Keywords Provided by Researchers

  • Candida auris
  • Decolonization
  • Colonization
  • Infection Prevention
  • Povidone Iodine
  • Long-term Care

Additional Relevant MeSH Terms

  • Candida Auris Infection
  • Colonization, Asymptomatic